Labiotech.eu

News and Trends 15 Nov 2017

Spanish Scientists’ Discovery Could be the End of Antibiotic-Resistant Superbugs

Superbugs might not be so super for long, as Spanish scientists have found a way to block the mechanisms by which they develop antibiotic resistance. Researchers from the Spanish National Research Council (CSIC) have made a big breakthrough in the battle against antibiotic-resistant bacteria. In a study published in Cell, they designed molecules that block the cellular […]

November 15, 2017 - 3 minutesmins - By Alex Dale

topas therapeutics timm jessen interview

Interview 15 Nov 2017

Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them

In our last BIO Europe interview, I caught up with CEO Timm Jessen of Topas Therapeutics to hear about the company’s nanoparticles. Founded in 2013 as a spinout from Evotec, Topas Therapeutics is developing nanoparticles for a whole range of diseases and with CEO Timm Jessen at the helm. He told me the story of […]

November 15, 2017 - 4 minutesmins - By Evelyn Warner

News and Trends 14 Nov 2017

This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected

Autolus has revealed a new strategy to treat T-cell lymphoma without harming healthy, protective T cells. The therapy is expected to start human tests soon. T-cell lymphoma is a form of cancer that affects the cells responsible for protecting our body against infections. Unlike it’s done with cancer types that affect other blood cells, it’s […]

November 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Nov 2017

It’s World Diabetes Day! But What is Biotech Doing to Fight the Disease?

Diabetes is now a major epidemic, with 425 million people living with the condition. Luckily, biotech is working on ways to stop it in its tracks. Not only is it Antibiotic Awareness Week, but today is World Diabetes Day. This year’s theme draws attention to diabetes in women and the right to live a healthy life. […]

November 14, 2017 - 4 minutesmins - By Alex Dale

News and Trends 14 Nov 2017

Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low

ProQR is aiming to raise funds for clinical trials on the Nasdaq despite the fact that its stock has been down for a while now. ProQR is a biotech based in Leiden that develops RNA therapies for genetic disorders, with its lead program focused on cystic fibrosis. In order to fund clinical trials, research and […]

November 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

tusk therapeutics cancer CD38 immunotherapy 1

News and Trends 14 Nov 2017

British Biotech Gets a £2.5M Grant to Boost Cancer Immunotherapy

Tusk Therapeutics is working on immunotherapies to ignite the immune system against cancer. The £2.5M grant will help it to accelerate their development. Tusk Therapeutics focuses on immuno-oncology to ‘harness the power’ of the immune system. One of its candidates is an antibody that targets the CD38 immune checkpoint, which is a marker of cell activation that […]

November 14, 2017 - 2 minutesmins - By Alex Dale

In Depth 14 Nov 2017

The World’s Deadliest Diseases: How is Biotech Fighting Them?

With the recent outbreaks of plague in Madagascar and Ebola in West Africa, two terrifying diseases are back in the news. But these are not the only infections that are inevitably fatal if untreated, or, even worse, for which no therapy is available yet. Though mostly rare, deadly diseases are closer than you think. Plague […]

November 14, 2017 - 7 minutesmins - By Ute Boronowsky

Hubert Birner TVM Capital Bio Europe 2017

Interview 13 Nov 2017

Where is the Money Going in Biotech? A Peek into European VC Strategy

Hubert Birner, Managing Partner at TVM Capital Life Science, discusses his strategy to adapt to the European funding constraints and the areas with most potential for biotech investment. TVM Capital Life Science is a venture capital firm focusing on biotech, pharma and medtech. With over €900M under management and offices in both Munich and Montreal, TVM […]

November 13, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

myocardial infarction diagnosis GlyCardial2 1

News and Trends 13 Nov 2017

Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late

GlyCardial Diagnostics believes it has the technology to prevent premature myocardial infarctions, 80% of which are preventable. Barcelona-based GlyCardial Diagnostics is a biotech, which spun-out from the Catalan Institute of Cardiovascular Science. The startup focuses on the development of an in vitro diagnostic device for myocardial ischemia, which is based on the detection of Apo J-Glyc in the […]

November 13, 2017 - 2 minutesmins - By Alex Dale

News and Trends 13 Nov 2017

World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance

This week marks the WHO’s World Antibiotic Awareness Week. We had a look at some of the best work being done by biotechs to fight resistance. An estimated 154 million prescriptions for antibiotics are written each year, but up to 30% are unnecessary. The World Health Organization has set up World Antibiotic Awareness Week to tackle this. This year’s theme is […]

November 13, 2017 - 3 minutesmins - By Alex Dale

News and Trends 13 Nov 2017

Biotech Unicorn’s T-Cell Receptor Therapy “Nearly Doubles” Survival in Uveal Melanoma

Immunocore, one of the only three European biotech unicorns, has presented Phase I results for its TCR immunotherapy IMCgp100 in patients suffering from metastatic uveal melanoma. Results are positive, but perhaps not to the level of expectation for a company with such a high valuation. On Saturday, Immunocore presented its latest clinical results at the Society […]

November 13, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 13 Nov 2017

British Biotech Gets PRIME Designation for its Brittle Bones Drug

The EMA has awarded PRIME Designation to Mereo BioPharma’s osteogenesis imperfecta drug, a condition for which there is no treatment on the market. Mereo acquires, develops and commercializes therapies for patients with rare diseases. It was set up by Denise Scots-Knight, one of our top women entrepreneurs, in 2015 and already has a market cap […]

November 13, 2017 - 1 minutemin - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Spanish Scientists’ Discovery Could be the End of Antibiotic-Resistant Superbugs

Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them

This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected

It’s World Diabetes Day! But What is Biotech Doing to Fight the Disease?

Dutch RNA Firm Announces a Public Offering when its Stock is at an All-Time Low

British Biotech Gets a £2.5M Grant to Boost Cancer Immunotherapy

The World’s Deadliest Diseases: How is Biotech Fighting Them?

Where is the Money Going in Biotech? A Peek into European VC Strategy

Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late

World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance

Biotech Unicorn’s T-Cell Receptor Therapy “Nearly Doubles” Survival in Uveal Melanoma

British Biotech Gets PRIME Designation for its Brittle Bones Drug

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!